{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:21:27Z","timestamp":1784013687749,"version":"3.55.0"},"reference-count":277,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS034239-28"],"award-info":[{"award-number":["R01 NS034239-28"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016764","name":"Fred and Pamela Buffett Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH121402-01A1"],"award-info":[{"award-number":["R01 MH121402-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P01 DA028555-06A1"],"award-info":[{"award-number":["P01 DA028555-06A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.nano.2023.102711","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:24:27Z","timestamp":1696649067000},"page":"102711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Delivery of gene editing therapeutics"],"prefix":"10.1016","volume":"54","author":[{"given":"Bhavesh D.","family":"Kevadiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Deol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubaba A.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"Mosselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Ashaduzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Bajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda Kishore","family":"Routhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Amol","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Dawre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitkumar K.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Nahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepali","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ullah","family":"Nayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Gounani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Bariwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Hettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4910","key":"10.1016\/j.nano.2023.102711_bb0005","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.2660260","article-title":"Altering the genome by homologous recombination","volume":"244","author":"Capecchi","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.nano.2023.102711_bb0010","series-title":"The Nobel Prize in Physiology or Medicine 2007","article-title":"The nobel prize in physiology or medicine 2007","author":"Capecchi SMJE","year":"2007"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0015","first-page":"8096","article-title":"Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease","volume":"14","author":"Rouet","year":"1994","journal-title":"Mol Cell Biol"},{"issue":"6096","key":"10.1016\/j.nano.2023.102711_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA&#x2013;guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0025","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0030","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.18609\/cgti.2017.005","article-title":"Recent advances in the use of ZFN-mediated gene editing for human gene therapy","volume":"3","author":"Chandrasegaran","year":"2017","journal-title":"Cell Gene Ther. Insights"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0040","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nprot.2006.231","article-title":"Design, construction and in vitro testing of zinc finger nucleases","volume":"1","author":"Carroll","year":"2006","journal-title":"Nat Protoc"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of <i>Angptl3<\/i>","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0055","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41467-019-08867-x","article-title":"Diversifying the structure of zinc finger nucleases for high-precision genome editing","volume":"10","author":"Paschon","year":"2019","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0060","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nbt1410","article-title":"Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases","volume":"26","author":"Perez","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0065","doi-asserted-by":"crossref","first-page":"100007","DOI":"10.1016\/j.ggedit.2021.100007","article-title":"TALE and TALEN genome editing technologies","volume":"2","author":"Becker","year":"2021","journal-title":"Gene Genome Editing"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cbic.201402408","article-title":"Achieving single-nucleotide resolution of 5-methylcytosine detection with TALEs","volume":"16","author":"Kubik","year":"2015","journal-title":"Chembiochem"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0075","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/nar\/gkt1224","article-title":"megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering","volume":"42","author":"Boissel","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1534\/g3.114.011445","article-title":"The I-TevI nuclease and linker domains contribute to the specificity of monomeric TALENs","volume":"4","author":"Kleinstiver","year":"2014","journal-title":"G3 (Bethesda)"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nmeth.2364","article-title":"TALENs and ZFNs are associated with different mutation signatures","volume":"10","author":"Kim","year":"2013","journal-title":"Nat. Methods"},{"issue":"374","key":"10.1016\/j.nano.2023.102711_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2013","article-title":"Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells","volume":"9","author":"Qasim","year":"2017","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0095","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/nar\/gkaa477","article-title":"5\u2032 modifications to CRISPR\u2013Cas9 gRNA can change the dynamics and size of R-loops and inhibit DNA cleavage","volume":"48","author":"Mullally","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2023.102711_bb0105","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.omtn.2021.08.008","article-title":"The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy","volume":"26","author":"Cui","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"15","key":"10.1016\/j.nano.2023.102711_bb0110","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.7150\/thno.25958","article-title":"Aptamers in the therapeutics and diagnostics pipelines","volume":"8","author":"Kaur","year":"2018","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0115","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0120","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2958.1993.tb00976.x","article-title":"Nature of DNA polymorphism in the direct repeat cluster of mycobacterium tuberculosis; application for strain differentiation by a novel typing method","volume":"10","author":"Groenen","year":"1993","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","article-title":"Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria","volume":"36","author":"Mojica","year":"2000","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0130","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1365-2958.2002.02839.x","article-title":"Identification of genes that are associated with DNA repeats in prokaryotes","volume":"43","author":"Jansen","year":"2002","journal-title":"Mol Microbiol"},{"issue":"17","key":"10.1016\/j.nano.2023.102711_bb0135","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1111\/febs.13766","article-title":"The discovery of CRISPR in archaea and bacteria","volume":"283","author":"Mojica","year":"2016","journal-title":"FEBS J"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0010060","article-title":"A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR\/Cas subtypes exist in prokaryotic genomes","volume":"1","author":"Haft","year":"2005","journal-title":"PLoS Comput Biol"},{"issue":"Pt 8","key":"10.1016\/j.nano.2023.102711_bb0145","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiol (Reading)"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6150-1-7","article-title":"A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action","volume":"1","author":"Makarova","year":"2006","journal-title":"Biol Direct"},{"issue":"5819","key":"10.1016\/j.nano.2023.102711_bb0160","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"issue":"5891","key":"10.1016\/j.nano.2023.102711_bb0165","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.1159689","article-title":"Small CRISPR RNAs guide antiviral defense in prokaryotes","volume":"321","author":"Brouns","year":"2008","journal-title":"Science"},{"issue":"7340","key":"10.1016\/j.nano.2023.102711_bb0170","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature09886","article-title":"CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III","volume":"471","author":"Deltcheva","year":"2011","journal-title":"Nature"},{"issue":"39","key":"10.1016\/j.nano.2023.102711_bb0175","doi-asserted-by":"crossref","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9\u2013crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6121","key":"10.1016\/j.nano.2023.102711_bb0180","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nbt.2501","article-title":"Efficient genome editing in zebrafish using a CRISPR-Cas system","volume":"31","author":"Hwang","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0195","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nplants.2017.18","article-title":"A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants","volume":"3","author":"Tang","year":"2017","journal-title":"Nat Plants"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/crispr.2018.0033","article-title":"Classification and nomenclature of CRISPR-Cas systems: where from here?","volume":"1","author":"Makarova","year":"2018","journal-title":"CRISPR J"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0205","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41467-018-04252-2","article-title":"The CRISPR tool kit for genome editing and beyond","volume":"9","author":"Adli","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/mutage\/15.4.289","article-title":"Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations","volume":"15","author":"Pfeiffer","year":"2000","journal-title":"Mutagenesis"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/acschembio.7b00760","article-title":"Repair of a site-specific DNA cleavage: old-school lessons for Cas9-mediated gene editing","volume":"13","author":"Gallagher","year":"2018","journal-title":"ACS Chem Biol"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3390\/biom10060839","article-title":"Recent advances in CRISPR\/Cas9 delivery strategies","volume":"10","author":"Yip","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0225","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247603","article-title":"Systematic analysis of factors that improve homologous direct repair (HDR) efficiency in CRISPR\/Cas9 technique","volume":"16","author":"Di Stazio","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.nano.2023.102711_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mimet.2017.06.010","article-title":"A two-plasmid inducible CRISPR\/Cas9 genome editing tool for clostridium acetobutylicum","volume":"140","author":"Wasels","year":"2017","journal-title":"J Microbiol Methods"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0240","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cr.2014.160","article-title":"Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells","volume":"25","author":"Wu","year":"2015","journal-title":"Cell Res"},{"issue":"29","key":"10.1016\/j.nano.2023.102711_bb0245","doi-asserted-by":"crossref","first-page":"eabb4005","DOI":"10.1126\/sciadv.abb4005","article-title":"Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects","volume":"6","author":"Deng","year":"2020","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0250","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI79743","article-title":"A versatile modular vector system for rapid combinatorial mammalian genetics","volume":"125","author":"Albers","year":"2015","journal-title":"J Clin Investig"},{"issue":"19","key":"10.1016\/j.nano.2023.102711_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku749","article-title":"Multiplex CRISPR\/Cas9-based genome engineering from a single lentiviral vector","volume":"42","author":"Kabadi","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/pharmaceutics7030213","article-title":"Image-guided hydrodynamic gene delivery: current status and future directions","volume":"7","author":"Kamimura","year":"2015","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0265","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","article-title":"Delivery aspects of CRISPR\/Cas for in vivo genome editing","volume":"52","author":"Wilbie","year":"2019","journal-title":"Acc Chem Res"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0270","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2023.102711_bb0275","doi-asserted-by":"crossref","first-page":"702445","DOI":"10.3389\/fphar.2021.702445","article-title":"The application of inorganic nanoparticles in molecular targeted cancer therapy: EGFR targeting","volume":"12","author":"Sun","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt.3081","article-title":"Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo","volume":"33","author":"Zuris","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"28","key":"10.1016\/j.nano.2023.102711_bb0285","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1074\/jbc.M116.733154","article-title":"Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes","volume":"291","author":"Chen","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2023.102711_bb0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.omtn.2021.08.014","article-title":"Cas9 RNP transfection by vapor nanobubble photoporation for ex vivo cell engineering","volume":"25","author":"Raes","year":"2021","journal-title":"Mol. Ther Nucleic Acids"},{"key":"10.1016\/j.nano.2023.102711_bb0295","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.omtn.2018.06.010","article-title":"Uridine depletion and chemical modification increase Cas9 mRNA activity and reduce immunogenicity without HPLC purification","volume":"12","author":"Vaidyanathan","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0300","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/mt.2012.7","article-title":"Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin","volume":"20","author":"Karik\u00f3","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jbiotec.2016.06.011","article-title":"Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing","volume":"233","author":"Kelley","year":"2016","journal-title":"J Biotechnol"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0310","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s13238-018-0552-5","article-title":"5\u2032 capped and 3\u2032 polyA-tailed sgRNAs enhance the efficiency of CRISPR-Cas9 system","volume":"10","author":"Mu","year":"2019","journal-title":"Protein Cell"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0315","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41587-019-0095-1","article-title":"Increasing the specificity of CRISPR systems with engineered RNA secondary structures","volume":"37","author":"Kocak","year":"2019","journal-title":"Nat. Biotechnol"},{"issue":"11","key":"10.1016\/j.nano.2023.102711_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188593","article-title":"Minimal 2\u2019-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity","volume":"12","author":"Basila","year":"2017","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0325","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis"},{"issue":"13","key":"10.1016\/j.nano.2023.102711_bb0330","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1073\/pnas.1717725115","article-title":"Programmable RNA recognition using a CRISPR-associated Argonaute","volume":"115","author":"Lapinaite","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0335","doi-asserted-by":"crossref","DOI":"10.4172\/2576-3881.1000121","article-title":"Chemical modification of CRISPR gRNAs eliminate type I interferon responses in human peripheral blood mononuclear cells","volume":"3","author":"Schubert","year":"2018","journal-title":"J Cytokine Biol"},{"issue":"19","key":"10.1016\/j.nano.2023.102711_bb0340","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1039\/C7CC08893K","article-title":"A G-quadruplex motif at the 3\u2032 end of sgRNAs improves CRISPR\u2013Cas9 based genome editing efficiency","volume":"54","author":"Nahar","year":"2018","journal-title":"Chem Commun"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb0345","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.tibtech.2019.01.009","article-title":"Improving CRISPR genome editing by engineering guide RNAs","volume":"37","author":"Moon","year":"2019","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0350","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1038\/ncomms9083","article-title":"Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries","volume":"6","author":"Vidigal","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0355","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-019-09600-4","article-title":"An artificial triazole backbone linkage provides a split-and-click strategy to bioactive chemically modified CRISPR sgRNA","volume":"10","author":"Taemaitree","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-05073-z","article-title":"Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing","volume":"9","author":"Mir","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0365","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0370","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.omtn.2020.01.004","article-title":"Development of a facile approach for generating chemically modified CRISPR\/Cas9 RNA","volume":"19","author":"Scott","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.nano.2023.102711_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2020.617910","article-title":"Using synthetically engineered guide RNAs to enhance CRISPR genome editing Systems in Mammalian Cells","volume":"2","author":"Allen","year":"2021","journal-title":"Front Genome Editing"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0380","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2012.12.029","article-title":"Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format","volume":"166","author":"Phua","year":"2013","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0385","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/anie.201610209","article-title":"Non-viral CRISPR\/Cas gene editing in vitro and in vivo enabled by synthetic nanoparticle co-delivery of Cas9 mRNA and sgRNA","volume":"56","author":"Miller","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0390","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.molcel.2021.12.002","article-title":"The CRISPR-Cas toolbox and gene editing technologies","volume":"82","author":"Liu","year":"2022","journal-title":"Mol Cell"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0395","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/thno.43360","article-title":"Advances in CRISPR\/Cas-based gene therapy in human genetic diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0400","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1089\/crispr.2020.29116.smi","article-title":"Assessing off-target editing of CRISPR-cas9 systems","volume":"3","author":"Pruett-Miller","year":"2020","journal-title":"CRISPR J"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0405","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0410","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR\u2013Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat Methods"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0415","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00335-017-9697-4","article-title":"CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools","volume":"28","author":"Cebrian-Serrano","year":"2017","journal-title":"Mamm Genome"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0420","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acschembio.7b00657","article-title":"CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine","volume":"13","author":"Kampmann","year":"2018","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0425","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"7681","key":"10.1016\/j.nano.2023.102711_bb0430","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"issue":"7603","key":"10.1016\/j.nano.2023.102711_bb0435","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0440","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41434-021-00263-9","article-title":"Prime editing \u2013 an update on the field","volume":"28","author":"Scholefield","year":"2021","journal-title":"Gene Ther"},{"issue":"7785","key":"10.1016\/j.nano.2023.102711_bb0445","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0450","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heckl","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0455","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.1976.tb29328.x","article-title":"The future for gene therapy--a reevaluation","volume":"265","author":"Friedmann","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nano.2023.102711_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00148","article-title":"Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases","volume":"13","author":"Rittiner","year":"2020","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0470","author":"Emily Capra"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0475","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/gt.2011.12","article-title":"Risk assessment in skin gene therapy: viral\u2013cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors","volume":"18","author":"Almarza","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0480","doi-asserted-by":"crossref","first-page":"975803","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0485","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/mthe.2002.0549","article-title":"Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood","volume":"5","author":"Hanawa","year":"2002","journal-title":"Mol Ther"},{"issue":"14","key":"10.1016\/j.nano.2023.102711_bb0490","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1073\/pnas.96.14.7791","article-title":"Recruitment of cyclin T1\/P-TEF\u03b2 to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription","volume":"96","author":"Bieniasz","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0495","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0960-9822(06)00335-6","article-title":"The importin-beta family member Crm1p bridges the interaction between rev and the nuclear pore complex during nuclear export","volume":"7","author":"Neville","year":"1997","journal-title":"Curr Biol"},{"issue":"11","key":"10.1016\/j.nano.2023.102711_bb0500","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/v9110322","article-title":"Hijacking of the ubiquitin\/proteasome pathway by the HIV auxiliary proteins","volume":"9","author":"Seissler","year":"2017","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0505","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/mt.2011.288","article-title":"Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?","volume":"20","author":"Bear","year":"2012","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0510","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0515","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0520","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.omtm.2020.10.012","article-title":"CReVIS-Seq: a highly accurate and multiplexable method for genome-wide mapping of lentiviral integration sites","volume":"20","author":"Kim","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0525","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/gt.2009.46","article-title":"Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector","volume":"16","author":"Tian","year":"2009","journal-title":"Gene Ther"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0530","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.3390\/ijms22105240","article-title":"Adenovirus structure: what is new?","volume":"22","author":"Gallardo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0535","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.cgt.7701054","article-title":"Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy","volume":"14","author":"Yang","year":"2007","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb0540","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkv187","article-title":"Distribution of DNA-condensing protein complexes in the adenovirus core","volume":"43","author":"P\u00e9rez-Bern\u00e1","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0545","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.gt.3302612","article-title":"Gutless adenovirus: last-generation adenovirus for gene therapy","volume":"12","author":"Alba","year":"2005","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0550","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1161\/01.CIR.100.5.468","article-title":"Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease","volume":"100","author":"Rosengart","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0555","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0560","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","article-title":"Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses","volume":"26","author":"Wang","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"17","key":"10.1016\/j.nano.2023.102711_bb0565","doi-asserted-by":"crossref","first-page":"i656","DOI":"10.1093\/bioinformatics\/bty554","article-title":"Off-target predictions in CRISPR-Cas9 gene editing using deep learning","volume":"34","author":"Lin","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.nano.2023.102711_bb0570","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ebiom.2018.02.015","article-title":"Therapeutic genome editing with CRISPR\/Cas9 in a humanized mouse model ameliorates \u03b11-antitrypsin deficiency phenotype","volume":"29","author":"Bjursell","year":"2018","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0575","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2141.2003.04719.x","article-title":"Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance","volume":"123","author":"Wolins","year":"2003","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1016\/j.nano.2023.102711_bb0580","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1093\/nar\/gkx490","article-title":"Selective disruption of an oncogenic mutant allele by CRISPR\/Cas9 induces efficient tumor regression","volume":"45","author":"Koo","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0585","first-page":"351","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3685","key":"10.1016\/j.nano.2023.102711_bb0590","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-associated defective virus particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0595","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/jvi.34.2.402-409.1980","article-title":"Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA","volume":"34","author":"Lusby","year":"1980","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2023.102711_bb0600","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jconrel.2021.10.031","article-title":"Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery","volume":"341","author":"Swingle","year":"2022","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0605","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0610","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/hum.1996.7.9-1145","article-title":"A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Johns Hopkins Children\u2019s Center, Baltimore, Maryland","volume":"7","author":"Flotte","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0615","series-title":"Fields Virology","volume":"Vols. 1 and 2","author":"Knipe","year":"2013"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0620","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/75080","article-title":"A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation","volume":"6","author":"Duan","year":"2000","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0625","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nchembio.1793","article-title":"Small molecule\u2013triggered Cas9 protein with improved genome-editing specificity","volume":"11","author":"Davis","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0630","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nbt.3155","article-title":"Inducible in vivo genome editing with CRISPR-Cas9","volume":"33","author":"Dow","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0635","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging issues in AAV-mediated in vivo gene therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0640","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0645","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41417-021-00413-6","article-title":"Safety of adeno-associated virus-based vector-mediated gene therapy\u2014impact of vector dose","volume":"29","author":"Maurya","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.nano.2023.102711_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00868","article-title":"Development and clinical translation of approved gene therapy products for genetic disorders","volume":"10","author":"Shahryari","year":"2019","journal-title":"Front Genet"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0655","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","article-title":"Virus-like particles as immunogens","volume":"11","author":"Noad","year":"2003","journal-title":"Trends Microbiol"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0665","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0670","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","article-title":"Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins","volume":"10","author":"Mangeot","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0675","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-022-01550-8","article-title":"Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy","volume":"21","author":"Lan","year":"2022","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0680","first-page":"GE01","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0685","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12248-021-00608-7","article-title":"Non-viral vectors in gene therapy: recent development, challenges, and prospects","volume":"23","author":"Zu","year":"2021","journal-title":"AAPS J"},{"key":"10.1016\/j.nano.2023.102711_bb0690","doi-asserted-by":"crossref","first-page":"100766","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2023.102711_bb0695","series-title":"Strategies to Modify the Drug Release from Pharmaceutical Systems","first-page":"15","article-title":"2 - Modification of drug release","year":"2015"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb0700","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0705","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2217\/nnm-2019-0443","article-title":"Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases","volume":"15","author":"Cano","year":"2020","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0710","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/antibiotics8040260","article-title":"The use of nanomedicine for targeted therapy against bacterial infections","volume":"8","author":"Masri","year":"2019","journal-title":"Antibiotics"},{"issue":"17","key":"10.1016\/j.nano.2023.102711_bb0715","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.drudis.2012.05.010","article-title":"Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy","volume":"17","author":"Parhi","year":"2012","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0720","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1021\/bc200111p","article-title":"Biologically optimized nanosized molecules and particles: more than just size","volume":"22","author":"Longmire","year":"2011","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2023.102711_bb0725","series-title":"Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats","author":"Longmire","year":"2008"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0730","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles:applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0735","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sj.mt.6300326","article-title":"Breaking the bonds: non-viral vectors become chemically dynamic","volume":"16","author":"Wolff","year":"2008","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0740","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2010.03.019","article-title":"Gene delivery by lipoplexes and polyplexes","volume":"40","author":"Tros de Ilarduya","year":"2010","journal-title":"Eur J Pharm Sci"},{"issue":"32","key":"10.1016\/j.nano.2023.102711_bb0745","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2023.102711_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.02.003","article-title":"Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics","volume":"203","author":"Lorenzer","year":"2015","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0755","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"10.1016\/j.nano.2023.102711_bb0760","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bpj.2021.03.012","article-title":"Encapsulation state of messenger RNA inside lipid nanoparticles","volume":"120","author":"Brader","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.nano.2023.102711_bb0765","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr Opin Biotechnol"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb0770","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1021\/acs.nanolett.0c01386","article-title":"Deconvoluting lipid nanoparticle structure for messenger RNA delivery","volume":"20","author":"Eygeris","year":"2020","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2023.102711_bb0775","series-title":"Nanocarriers for Drug Delivery","first-page":"249","article-title":"Chapter 8 - lipid-based nanoparticles for drug-delivery systems","author":"Kumar","year":"2019"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb0780","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/1389201017666160415155457","article-title":"Lipid nanoparticles and their application in nanomedicine","volume":"17","author":"Rajabi","year":"2016","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb0785","series-title":"Advances in Genetics","first-page":"13","article-title":"Chapter two - lipid nanoparticles for gene delivery","author":"Huang","year":"2014"},{"issue":"15","key":"10.1016\/j.nano.2023.102711_bb0790","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.gt.3301506","article-title":"On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids","volume":"8","author":"Hafez","year":"2001","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0795","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/bc300381s","article-title":"The headgroup evolution of cationic lipids for gene delivery","volume":"24","author":"Zhi","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0800","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"32","key":"10.1016\/j.nano.2023.102711_bb0805","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1073\/pnas.1306529110","article-title":"Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery","volume":"110","author":"Alabi","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0810","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/pharmaceutics5030498","article-title":"Advances in lipid nanoparticles for siRNA delivery","volume":"5","author":"Tam","year":"2013","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0815","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep"},{"issue":"16","key":"10.1016\/j.nano.2023.102711_bb0820","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb0825","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/gt.2011.34","article-title":"Explorations of high-intensity therapeutic ultrasound and microbubble-mediated gene delivery in mouse liver","volume":"18","author":"Song","year":"2011","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0830","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/mt.2013.291","article-title":"Delivery of therapeutic siRNA to the lung endothelium via novel lipoplex formulation DACC","volume":"22","author":"Fehring","year":"2014","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb0835","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.gt.3300863","article-title":"Lipoplex size is a major determinant of in vitro lipofection efficiency","volume":"6","author":"Ross","year":"1999","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0840","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0005-2736(97)00126-0","article-title":"Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells","volume":"1329","author":"Filion","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.nano.2023.102711_bb0845","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.addr.2012.06.013","article-title":"Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticles","volume":"64","author":"Peer","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0850","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2023.102711_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0860","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/mt.2011.141","article-title":"Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery","volume":"19","author":"Whitehead","year":"2011","journal-title":"Mol Ther"},{"issue":"21","key":"10.1016\/j.nano.2023.102711_bb0865","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0870","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jconrel.2005.08.012","article-title":"The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route","volume":"108","author":"Hattori","year":"2005","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0875","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb0880","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/ijerph13121182","article-title":"Recent advances on inorganic nanoparticle-based cancer therapeutic agents","volume":"13","author":"Wang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"28","key":"10.1016\/j.nano.2023.102711_bb0885","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1021\/acs.jpcb.5b02891","article-title":"Microfluidic mixing: a general method for encapsulating macromolecules in lipid nanoparticle systems","volume":"119","author":"Leung","year":"2015","journal-title":"J Phys Chem B"},{"issue":"11","key":"10.1016\/j.nano.2023.102711_bb0890","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett"},{"issue":"38","key":"10.1016\/j.nano.2023.102711_bb0895","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.1021\/jp034922a","article-title":"Differential properties of the sterols cholesterol, ergosterol, \u03b2-sitosterol, trans-7-dehydrocholesterol, stigmasterol and lanosterol on DPPC bilayer order","volume":"107","author":"Bernsdorff","year":"2003","journal-title":"J Phys Chem B"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0900","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-4165(95)00170-0","article-title":"Effects of cholesterol on the lamellar and the inverted hexagonal phases of dielaidoylphosphatidylethanolamine","volume":"1289","author":"Takahashi","year":"1996","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0905","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0939-6411(01)00165-5","article-title":"Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system","volume":"52","author":"Sakurai","year":"2001","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0910","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbamem.2012.05.017","article-title":"Transfection efficiency boost of cholesterol-containing lipoplexes","volume":"1818","author":"Pozzi","year":"2012","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.nano.2023.102711_bb0915","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0920","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0169-409X(95)00022-Y","article-title":"Which polymers can make nanoparticulate drug carriers long-circulating?","volume":"16","author":"Torchilin","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0925","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0169-409X(94)90016-7","article-title":"The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system","volume":"13","author":"Allen","year":"1994","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2023.102711_bb0930","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0935","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2023.102711_bb0940","series-title":"Antisense Drug Technology","first-page":"255","article-title":"Liposomal formulations for nucleic acid delivery","author":"MacLachlan","year":"2007"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb0945","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1021\/ja0318030","article-title":"Controlled vesicle self-assembly in microfluidic channels with hydrodynamic focusing","volume":"126","author":"Jahn","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb0950","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1081\/LPR-120014761","article-title":"The crossflow injection technique: an improvement of the ethanol injection method","volume":"12","author":"Wagner","year":"2002","journal-title":"J Liposome Res"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0955","doi-asserted-by":"crossref","DOI":"10.3390\/nano10020190","article-title":"Immunological and toxicological considerations for the design of liposomes","volume":"10","author":"Inglut","year":"2020","journal-title":"Nanomaterials (Basel)"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0960","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jcp.1040730108","article-title":"Formation and properties of thin-walled phospholipid vesicles","volume":"73","author":"Reeves","year":"1969","journal-title":"J Cell Physiol"},{"issue":"19","key":"10.1016\/j.nano.2023.102711_bb0965","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New developments in liposomal drug delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb0970","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(02)00130-3","article-title":"Solvent injection as a new approach for manufacturing lipid nanoparticles \u2013 evaluation of the method and process parameters","volume":"55","author":"Schubert","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"issue":"20","key":"10.1016\/j.nano.2023.102711_bb0975","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/molecules25204781","article-title":"Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method","volume":"25","author":"Duong","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0980","first-page":"103","article-title":"Applications of solid lipid nanoparticle in novel drug delivery system","volume":"1","author":"Jagdevappa","year":"2013","journal-title":"Br Biomed Bull"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb0985","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acs.jpclett.1c03898","article-title":"Opportunities and challenges for mRNA delivery nanoplatforms","volume":"13","author":"Zhang","year":"2022","journal-title":"J Phys Chem Lett"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb0990","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1021\/acsnano.7b04734","article-title":"Next-generation lipids in RNA interference therapeutics","volume":"11","author":"Rietwyk","year":"2017","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb0995","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijpharm.2017.12.035","article-title":"Critical evaluation of quantification methods for oligonucleotides formulated in lipid nanoparticles","volume":"548","author":"Oude Blenke","year":"2018","journal-title":"Int J Pharmacol"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb1000","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1021\/acs.chemrev.6b00848","article-title":"Emerging droplet microfluidics","volume":"117","author":"Shang","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2023.102711_bb1005","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2019.06.002","article-title":"Formulation and manufacturing of lymphatic targeting liposomes using microfluidics","volume":"307","author":"Khadke","year":"2019","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb1010","doi-asserted-by":"crossref","first-page":"1700375","DOI":"10.1002\/smtd.201700375","article-title":"State-of-the-art design and rapid-mixing production techniques of lipid nanoparticles for nucleic acid delivery","volume":"2","author":"Evers","year":"2018","journal-title":"Small Methods"},{"key":"10.1016\/j.nano.2023.102711_bb1015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.colsurfb.2017.05.033","article-title":"High-throughput continuous production of liposomes using hydrodynamic flow-focusing microfluidic devices","volume":"156","author":"Michelon","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2023.102711_bb1020","doi-asserted-by":"crossref","first-page":"120826","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb1025","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acs.molpharmaceut.0c00913","article-title":"Recent advances in microfluidics for the preparation of drug and gene delivery systems","volume":"17","author":"Tomeh","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2023.102711_bb1030","first-page":"6(47)","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","author":"Rosenblum","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2023.102711_bb1035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejpb.2021.03.012","article-title":"Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery","volume":"163","author":"Le-Vinh","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11095-013-1171-8","article-title":"Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms","volume":"31","author":"Andar","year":"2014","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb1045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb1050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys Rev"},{"key":"10.1016\/j.nano.2023.102711_bb1055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2019.02.030","article-title":"Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity","volume":"299","author":"Caputo","year":"2019","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb1060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s11095-010-0073-2","article-title":"Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates","volume":"27","author":"Filipe","year":"2010","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-022X(03)00059-9","article-title":"Characterization of loaded liposomes by size exclusion chromatography","volume":"56","author":"Grabielle-Madelmont","year":"2003","journal-title":"J Biochem Biophys Methods"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2004.07.010","article-title":"Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability","volume":"285","author":"Mohammed","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2023.102711_bb1075","doi-asserted-by":"crossref","first-page":"107711","DOI":"10.1016\/j.exer.2019.107711","article-title":"Investigating impacts of surface charge on intraocular distribution of intravitreal lipid nanoparticles","volume":"186","author":"Huang","year":"2019","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions","volume":"168","author":"Freitas","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2023.102711_bb1085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fphys.2011.00082","article-title":"FRET in membrane biophysics: an overview","volume":"2","author":"Loura","year":"2011","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","article-title":"Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb1095","doi-asserted-by":"crossref","first-page":"1903432","DOI":"10.1002\/advs.201903432","article-title":"Dual supramolecular nanoparticle vectors enable CRISPR\/Cas9-mediated Knockin of Retinoschisin 1 gene\u2014a potential nonviral therapeutic solution for X-linked juvenile Retinoschisis","volume":"7","author":"Chou","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2023.102711_bb1100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/0148607181005003230","article-title":"Development of fat emulsions","volume":"5","author":"Wretlind","year":"1981","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.nano.2023.102711_bb1110","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J Control Release"},{"issue":"25","key":"10.1016\/j.nano.2023.102711_bb1115","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.vaccine.2019.04.074","article-title":"mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials","volume":"37","author":"Feldman","year":"2019","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.nano.2023.102711_bb1120","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb1125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00262-005-0064-z","article-title":"Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor\/self antigen","volume":"55","author":"Hess","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2023.102711_bb1130","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.omtn.2022.04.010","article-title":"Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice","volume":"28","author":"Bartesaghi","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7687","key":"10.1016\/j.nano.2023.102711_bb1135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","article-title":"Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents","volume":"553","author":"Gao","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb1140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt.3806","article-title":"Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes","volume":"35","author":"Staahl","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"15","key":"10.1016\/j.nano.2023.102711_bb1145","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","article-title":"CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery","volume":"117","author":"Wang","year":"2017","journal-title":"Chem Rev"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb1150","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb1155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41551-021-00794-x","article-title":"Lipid nanoparticles for the inhalation of mRNA","volume":"5","author":"Chang","year":"2021","journal-title":"Nat Biomed Eng"},{"issue":"23","key":"10.1016\/j.nano.2023.102711_bb1160","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1021\/acs.accounts.1c00493","article-title":"Recent advances in the noninvasive delivery of mRNA","volume":"54","author":"Qin","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2023.102711_bb1165","doi-asserted-by":"crossref","first-page":"118813","DOI":"10.1016\/j.ijpharm.2019.118813","article-title":"Nasal route for vaccine and drug delivery: features and current opportunities","volume":"572","author":"Lobaina","year":"2019","journal-title":"Int J Pharmacol"},{"issue":"14","key":"10.1016\/j.nano.2023.102711_bb1170","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/138161210791164108","article-title":"Potential of nanoparticulate drug delivery systems by intranasal administration","volume":"16","author":"Ali","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.nano.2023.102711_bb1175","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation","volume":"12","author":"Yadav","year":"2015","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb1180","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1021\/acs.molpharmaceut.0c00170","article-title":"Intranasal delivery and transfection of mRNA therapeutics in the brain using cationic liposomes","volume":"17","author":"Dhaliwal","year":"2020","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1185","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","author":"Riley","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2023.102711_bb1190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J Control Release"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb1195","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","article-title":"mRNA delivery for therapeutic anti-HER2 antibody expression in vivo","volume":"27","author":"Rybakova","year":"2019","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep20019","article-title":"Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich\u2019s ataxia","volume":"6","author":"Nabhan","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of Lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2023.102711_bb1210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives","volume":"154-155","author":"Samaridou","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"7607","key":"10.1016\/j.nano.2023.102711_bb1215","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41565-017-0043-5","article-title":"A modular platform for targeted RNAi therapeutics","volume":"13","author":"Kedmi","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2023.102711_bb1225","doi-asserted-by":"crossref","first-page":"8395","DOI":"10.2147\/IJN.S188016","article-title":"Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting","volume":"13","author":"Shobaki","year":"2018","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb1230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"issue":"11","key":"10.1016\/j.nano.2023.102711_bb1235","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb1240","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/dmd.106.009555","article-title":"Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules","volume":"34","author":"van de Water","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1124\/dmd.113.055434","article-title":"Biodistribution and metabolism studies of lipid nanoparticle\u2013formulated internally [3H]-labeled siRNA in mice","volume":"42","author":"Christensen","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1250","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.gt.3300350","article-title":"Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA","volume":"4","author":"Thierry","year":"1997","journal-title":"Gene Ther"},{"issue":"14","key":"10.1016\/j.nano.2023.102711_bb1255","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1089\/hum.1998.9.14-2083","article-title":"Biodistribution and gene expression of lipid\/plasmid complexes after systemic administration","volume":"9","author":"Mahato","year":"1998","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1260","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0168-3659(00)00293-5","article-title":"Characteristics and biodistribution of cationic liposomes and their DNA complexes","volume":"69","author":"Ishiwata","year":"2000","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1265","first-page":"82","article-title":"Novartis secures first CRISPR pharma collaborations","volume":"14","author":"Mullard","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.nano.2023.102711_bb1270","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt.2909","article-title":"Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification","volume":"32","author":"Guilinger","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb1280","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bpj.2009.08.063","article-title":"Pardaxin permeabilizes vesicles more efficiently by pore formation than by disruption","volume":"98","author":"Vad","year":"2010","journal-title":"Biophys J"},{"issue":"11","key":"10.1016\/j.nano.2023.102711_bb1285","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/acscentsci.9b00843","article-title":"Fine-tuning of hydrophobicity in amphiphilic polyaspartamide derivatives for rapid and transient expression of messenger RNA directed toward genome engineering in brain","volume":"5","author":"Kim","year":"2019","journal-title":"ACS Cent Sci"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1290","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/acsnano.7b07874","article-title":"Macrophage-specific in vivo gene editing using cationic lipid-assisted polymeric nanoparticles","volume":"12","author":"Luo","year":"2018","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1295","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The endosomal escape of nanoparticles: toward more efficient cellular delivery","volume":"30","author":"Smith","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"10","key":"10.1016\/j.nano.2023.102711_bb1300","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.nano.2023.102711_bb1305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1310","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1315","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1038\/ncomms14370","article-title":"Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization","volume":"8","author":"Senturk","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.nano.2023.102711_bb1320","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymthe.2018.10.008","article-title":"Optimization of CRISPR\/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements","volume":"27","author":"Lattanzi","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2023.102711_bb1325","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jbiotec.2016.11.011","article-title":"Enhanced CRISPR\/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA","volume":"241","author":"Liang","year":"2017","journal-title":"J Biotechnol"},{"issue":"7587","key":"10.1016\/j.nano.2023.102711_bb1330","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nano.2023.102711_bb1335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","article-title":"Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review","volume":"85","author":"Kanamala","year":"2016","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.nano.2023.102711_bb1340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000686","article-title":"A compact Cas9 ortholog from staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope","volume":"18","author":"Hu","year":"2020","journal-title":"PLoS Biol"},{"issue":"8","key":"10.1016\/j.nano.2023.102711_bb1345","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1023\/A:1015908831507","article-title":"Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture","volume":"7","author":"Chu","year":"1990","journal-title":"Pharm Res"},{"issue":"7","key":"10.1016\/j.nano.2023.102711_bb1350","first-page":"3431","article-title":"pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs","volume":"46","author":"Connor","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2023.102711_bb1355","first-page":"32(2)","article-title":"Liposomes as a gene delivery system","author":"Ropert","year":"1999","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"10.1016\/j.nano.2023.102711_bb1360","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41551-021-00786-x","article-title":"Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs","volume":"5","author":"Lokugamage","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.nano.2023.102711_bb1365","article-title":"An efficient CRISPR\/Cas9 platform for rapidly generating simultaneous mutagenesis of multiple gene Homoeologs in Allotetraploid oilseed rape","volume":"9","author":"Li","year":"2018","journal-title":"Front Plant Sci"},{"issue":"50","key":"10.1016\/j.nano.2023.102711_bb1370","doi-asserted-by":"crossref","first-page":"18197","DOI":"10.1002\/anie.201909264","article-title":"A photolabile semiconducting polymer nanotransducer for near-infrared regulation of CRISPR\/Cas9 gene editing","volume":"58","author":"Lyu","year":"2019","journal-title":"Angew Chem Int Ed"},{"issue":"12","key":"10.1016\/j.nano.2023.102711_bb1375","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2023.102711_bb1380","series-title":"Novel Gene Therapy Approaches","first-page":"3","article-title":"Targeted gene delivery: importance of administration routes","author":"Fumoto","year":"2013"},{"issue":"4","key":"10.1016\/j.nano.2023.102711_bb9000","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR\/Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol."}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342300062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342300062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:20:26Z","timestamp":1761549626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996342300062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":277,"alternative-id":["S154996342300062X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2023.102711","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of gene editing therapeutics","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2023.102711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102711"}}